Barry D. Quart, Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 9,948 shares at $17.50 ($175K) on 2019-10-03, disclosed to the SEC on 2019-10-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.43 | 806 | $15K | 8.5% |
| 2 | $17.50 | 4,571 | $80K | 45.8% |
| 3 | $17.50 | 4,571 | $80K | 45.8% |
| Total | $17.58 avg | 9,948 | $175K | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |